Pharmacist Resources
THALOMID® (thalidomide) in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma (MM).
THALOMID is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL).
THALOMID is not indicated as monotherapy for such ENL treatment in the presence of moderate to severe neuritis.
THALOMID is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.
THALOMID REMS® information for certified pharmacies
THALOMID is only dispensed from THALOMID REMS® program certified pharmacies.
As a THALOMID REMS® certified pharmacy, you must follow the requirements of the THALOMID REMS® program. You may download a guide to the program, a checklist for counseling patients, and the full prescribing information below.
The Celgene REMS Pharmacy Portal
In addition to calling the Celgene Customer Care Center to obtain a confirmation number for a prescription,
eligible pharmacies can obtain confirmation numbers using the Celgene REMS Pharmacy Portal at CelgeneREMSPharmacyPortal.com. Contact your Celgene Account Manager to see if your pharmacy
is eligible.
Please report adverse drug experiences that are suspected to be associated with the use of THALOMID
and any suspected pregnancy occurring during the treatment with THALOMID to Celgene using any of the
following methods:
REPORTING TO CELGENE |
|
Online: |
|
Email: |
|
Telephone: 1-908-673-9667 |
|
Toll-free: 1-800-640-7854 (Global Drug Safety & Risk Management) or |
|
Fax: 1-908-673-9115 |
|
Mail to: Global Drug Safety & Risk Management |
|
Other: Per individual agreement between the reporting organization and Celgene Global Drug Safety & Risk Management |
REPORTING TO THE FDA |
|
Adverse drug experiences that are suspected to be associated with the use of THALOMID and
|
|
Online: |
|
Telephone: 1-800-FDA-1088 |
|
Fax: 1-800-FDA-0178 |
|
Mail to: MedWatch |
For additional information about the THALOMID REMS® program, please contact the Celgene Customer Care Center at 1-888-423-5436
THALOMID® and THALOMID REMS® are registered trademarks of Celgene Corporation.
© 2013-2017. Celgene Corporation, www.celgene.com.
This website is intended for residents of the United States only.
